OPUS GENETICS, INC. (IRD)
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
Zoetis Announces Second Quarter 2026 Results
Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors
BlackSky Reports Second Quarter 2026 Results
Arbe Announces Second Quarter 2026 Financial Results
Gilat Demonstrates Breakthrough AI-Based Interference Detection and Cancellation Technology for Satellite Links
Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease
Federal Realty Announces Proposed Private Placement of $400 Million of Exchangeable Senior Notes
KVH Industries Reports Second Quarter 2026 Results
Nexstar Media Group Reports Record Quarterly Net Revenue of $2.0 Billion
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
Vistance Networks Board Approves Special Distribution
Via Announces Second Quarter 2026 Results
Sharon AI Reports Second Quarter 2026 Results
Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias